RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism
January 1994
in “The Journal of Steroid Biochemistry and Molecular Biology”
TLDR RU 58841 may treat acne, hair loss, and excessive hair growth.
The paper introduces a new topical antiandrogen called RU 58841 that has potential to treat acne, androgenetic alopecia, and hirsutism. It has a high affinity for androgen receptors and causes regression of the flank organ area without affecting deep accessory sex organs or testosterone levels. RU 58841 is a safe and effective topical antiandrogen that targets androgen receptors in the skin. It shows promise as a treatment for acne, androgenetic alopecia, and hirsutism. Further research is needed to confirm its effectiveness in humans.
View this study on sciencedirect.com →
Cited in this study
research Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study*
Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.
research Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.
Related
research Androgens/Androgen Receptor in the Management of Skin Diseases
Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.
research Acne
Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.
research RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism
RU 58841 may treat acne, hair loss, and excessive hair growth.